Valuation Thiogenesis Therapeutics, Corp.

Stocks

Delayed Toronto S.E. 11:47:15 23/10/2026 pm IST			5-day change	1st Jan Change
0.6200 ^CAD	+5.08%		+24.00%	-4.62%

23/09	Thiogenesis Therapeutics, Inc. Lists Phase 2 Clinical Trial to Pilot Study of TTI-0102 in Cystinosis	CI
07/08	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025
Market Cap ¹	22.54	33.43	27.61	33.69
Change	-	48.3%	-17.4%	22.03%
Enterprise Value (EV) ¹	16.34	26.35	23.76	32.08
Change	-	61.23%	-9.83%	34.99%
P/E	-3.74x	-5.8x	-8.65x	-4.25x
PBR	3.77x	6.04x	8.06x	58.7x
PEG	-0x	0.3x	0.2x	-0x
Capitalization / Revenue	-	-	-	-
EV / Revenue	-	-	-	-
EV / EBITDA	-	-	-	-
EV / EBIT	-8.14x	-5.06x	-6.64x	-4.34x
EV / FCF	-	-	-	-
FCF Yield	-	-	-	-
Dividend per Share ³	-	-	-	-
Rate of return	-	-	-	-
EPS ³	-0.1552	-0.1294	-0.0693	-0.1528
Distribution rate	-	-	-	-
Net sales	-	-	-	-
EBITDA	-	-	-	-
EBIT ¹	-2.009	-5.206	-3.579	-7.395
Net income ¹	-3.924	-5.063	-3.146	-7.426
Net Debt ¹	-6.196	-7.076	-3.848	-1.616
Reference price ³	0.5800	0.7500	0.6000	0.6500
Nbr of stocks (in thousands)	38,862	44,571	46,017	51,836
Announcement Date	28/04/23	29/04/24	25/04/25	30/04/26

¹CAD in Million²USD in Million³CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
THIOGENESIS THERAPEUTICS, CORP.	-	-	-	-	2.94Cr
WUXI APPTEC CO., LTD.	18.38x	6.48x	12.88x	1.62%	6.33TCr
ARGENX SE	30.22x	7.94x	26.49x	0.05%	5.49TCr
LONZA GROUP AG	36.58x	6.5x	19.41x	0.88%	5.33TCr
IQVIA HOLDINGS INC.	35.46x	3.44x	14.83x	-.--%	4.58TCr
BEONE MEDICINES AG	50.32x	5.82x	31.95x	-.--%	4.35TCr
REVOLUTION MEDICINES, INC.	-19.48x	188.5x	-20.74x	-.--%	4.02TCr
CELLTRION, INC.	29.02x	8.23x	21.28x	0.37%	3.35TCr
WUXI BIOLOGICS (CAYMAN) INC.	27.38x	5.77x	14.95x	-.--%	2.37TCr
GENMAB A/S	32.79x	5.99x	20.16x	-.--%	2.38TCr
Average	26.74x	26.52x	15.69x	0.32%	3.82TCr
Weighted average by Cap.	26.71x	25.51x	15.93x	0.43%